Overview

Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia

Status:
Terminated

Trial end date:
2006-01-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to determine whether voriconazole is as effective as antifungal prophylaxis in patients undergoing chemotherapy for acute myelogenous leukemia (AML). Hypothesis: Voriconazole is superior to placebo in the prophylaxis of lung infiltrates until day 21 after the start of induction chemotherapy.

Phase:

Phase 3

Details

Lead Sponsor:

University of Cologne

Treatments:

Voriconazole